Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus
There have been conflicting results regarding the effect of proton pump inhibitors (PPIs) as an adjunctive therapy to oral antidiabetic medication (OAM) in those with type 2 diabetes (T2DM). PPIs increase gastrin levels, causing a rise in insulin. No studies have evaluated the duration of PPI therap...
Main Authors: | Amy Trang, Jordan Bushman, Alexandra Halalau |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/5578265 |
Similar Items
-
Effect of Proton Pump Inhibitor Administration on Glycemic Parameters in Patients with Type 2 Diabetes Mellitus
by: Seyed Alireza Ebadi, et al.
Published: (2021-06-01) -
Long-term effects of proton pump inhibitors
by: Sethu
Published: (2015-04-01) -
Proton Pump Inhibitor Long-term Prescription, Is It Safe?
by: Tae Ho Kim
Published: (2020-06-01) -
Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
by: Simone Janett, et al.
Published: (2015-01-01) -
Potential adverse effects of long term use of Proton Pump Inhibitors
by: Shreyans M. Doshi, et al.
Published: (2016-07-01)